FIM
ABBV icon

Fernwood Investment Management’s AbbVie ABBV Stock Holding History

Fernwood Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.21M Sell
12,432
-258
-2% -$47.4K 0.77% 31
2024
Q3 		$2.51M Sell
12,690
-270
-2% -$50.4K 0.82% 30
2024
Q2 		$2.22M Sell
12,960
-1,159
-8% -$192K 0.69% 39
2024
Q1 		$2.54M Sell
14,119
-604
-4% -$104K 0.74% 35
2023
Q4 		$2.29M Buy
14,723
+2
+0% +$292 0.76% 34
2023
Q3 		$2.21M Buy
14,721
+1
+0% +$147 0.8% 33
2023
Q2 		$2.03M Buy
14,720
+1,318
+10% +$193K 0.72% 37
2023
Q1 		$2.14M Buy
13,402
+997
+8% +$152K 0.82% 33
2022
Q4 		$2M Buy
12,405
+1
+0% +$153 0.83% 30
2022
Q3 		$1.67M Sell
12,404
-605
-5% -$86.8K 0.7% 39
2022
Q2 		$1.99M Sell
13,009
-1,779
-12% -$272K 0.86% 30
2022
Q1 		$2.4M Sell
14,788
-872
-6% -$127K 0.84% 29
2021
Q4 		$2.12M Buy
15,660
+494
+3% +$58.4K 0.69% 41
2021
Q3 		$1.64M Buy
15,166
+201
+1% +$23K 0.56% 50
2021
Q2 		$1.69M Buy
14,965
+1,045
+8% +$118K 0.56% 52
2021
Q1 		$1.51M Sell
13,920
-275
-2% -$29.4K 0.55% 53
2020
Q4 		$1.52M Buy
14,195
+100
+0.7% +$9.61K 0.6% 50
2020
Q3 		$1.24M Buy
14,095
+500
+4% +$47.1K 0.58% 54
2020
Q2 		$1.33M Buy
13,595
+200
+1% +$17.6K 0.66% 48
2020
Q1 		$1.02M Sell
13,395
-185
-1% -$15.8K 0.65% 48
2019
Q4 		$1.2M Sell
13,580
-100
-0.7% -$8.3K 0.57% 52
2019
Q3 		$1.04M Sell
13,680
-1,500
-10% -$103K 0.51% 55
2019
Q2 		$1.1M Sell
15,180
-125
-0.8% -$9.82K 0.6% 51
2019
Q1 		$1.23M Hold
15,305
– – 0.66% 47
2018
Q4 		$1.41M Sell
15,305
-100
-0.6% -$8.79K 0.91% 35
2018
Q3 		$1.46M Sell
15,405
-400
-3% -$37.9K 0.77% 43
2018
Q2 		$1.46M Sell
15,805
-200
-1% -$19.5K 0.79% 41
2018
Q1 		$1.51M Sell
16,005
-1,500
-9% -$165K 0.85% 36
2017
Q4 		$1.69M Hold
17,505
– – 0.91% 32
2017
Q3 		$1.55M Hold
17,505
– – 0.97% 27
2017
Q2 		$1.27M Hold
17,505
– – 0.92% 28
2017
Q1 		$1.14M Buy
17,505
+1,000
+6% +$62.9K 0.91% 30
2016
Q4 		$1.03M Hold
16,505
– – 0.99% 30
2016
Q3 		$1.04M Sell
16,505
-250
-1% -$16.2K 0.95% 32
2016
Q2 		$1.04M Hold
16,755
– – 1.02% 31
2016
Q1 		$957K Buy
16,755
+2,400
+17% +$134K 0.97% 34
2015
Q4 		$850K Sell
14,355
-428
-3% -$24.7K 0.73% 40
2015
Q3 		$804K Hold
14,783
– – 0.7% 46
2015
Q2 		$993K Hold
14,783
– – 0.78% 43
2015
Q1 		$865K Sell
14,783
-400
-3% -$24.2K 0.71% 45
2014
Q4 		$994K Buy
15,183
+8,024
+112% +$506K 0.85% 37
2014
Q3 		$414K Hold
7,159
– – 0.36% 68
2014
Q2 		$404K Sell
7,159
-2,400
-25% -$126K 0.33% 74
2014
Q1 		$491K Sell
9,559
-125
-1% -$6.32K 0.46% 60
2013
Q4 		$511K Buy
+9,684
New +$476K 0.34% 78

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fernwood Investment Management's ABBV Position: Q4 2024 in Review

Fernwood Investment Management reduced its AbbVie (ABBV) stake by 2% in Q4 2024, selling an estimated $47.4K and leaving 12,432 shares worth $2.21M. The position accounts for 0.77% of the portfolio, ranked #31.

Fernwood Investment Management first reported a position in ABBV in Q4 2013 and has held it in 45 quarters since. The position peaked at $2.54M in Q1 2024. 3,745 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Fernwood Investment Management held 12,432 shares of AbbVie worth $2.21M as of Q4 2024.
  • Fernwood Investment Management sold 258 AbbVie shares in Q4 2024, an estimated $47.4K.
  • AbbVie made up 0.77% of Fernwood Investment Management's portfolio in Q4 2024, its #31 holding.
  • Fernwood Investment Management first reported a position in AbbVie in Q4 2013 and has held it in 45 quarters since.
  • Fernwood Investment Management's AbbVie position peaked at $2.54M in Q1 2024.
  • 3,745 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.